Part 4 Know AKI and say no to acute kidney injury for patients | Andy Shaw on Acute Kidney Injury (AKI) biomarkers

This podcast is part 4 in a series which is supported by the "Know AKI campaign", a bioMérieux global campaign to raise awareness about AKI. For part one go here: https://topmedtalk.libsyn.com/part-1-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-renal-injury For part two go here: https://topmedtalk.libsyn.com/part-2-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-aki-recomendations-and-research-priorities-from-adqi-24poqi-7 And for part three follow this link here: https://topmedtalk.libsyn.com/part-3-know-aki-and-say-no-to-acute-kidney-injury-for-patients-health-systems-perspectives-in-aki Acute kidney injury (AKI) is an important topic for anyone practicing value based care, here we learn how research is developing and where the debate is at as regards biomarkers; what do the data tell us, where can improvements be made and why is it so important? This piece was originally available to attendees of EBPOM 2021 where it was this year's Siobhan Mythen Visiting Plenary lecture. You can watch a video of this lecture in the on demand section of of the EBPOM Education Hub (www.ebpom.live.org). Presented by Andy Shaw, Department of Intensive Care and Resuscitation at The Cleveland Clinic, Cleveland, Ohio, Fellow of the Royal College of Physicians and Surgeons of Canada, a Fellow of the Royal College of Anaesthetists (UK), a Fellow of the American College of Critical Care Medicine and a Fellow of the Faculty of Intensive Care Medicine (UK).